Arnd Kaltofen-Ehmann

Arnd Kaltofen-Ehmann currently works at Inositec AG, as Director, Araris Biotech AG, as Director from 2020, and VI Partners AG, as Managing Partner from 2018.
Dr. Kaltofen-Ehmann also formerly worked at Oncalis AG, as Chairman from 2009 to 2011, JenaValve Technology GmbH, as Director, Spinelab AG, as Director, Vectura GmbH, as Director-Supervisory Board, Cardiola AG, as Director-Executive Board from 2009 to 2012, Cell Medica Switzerland AG, as Director, Kuros Biosciences Ltd., as Director, Thommen Medical AG, as Member-Management Board, ESBATech, a Novartis Co. GmbH, as Member-Management Board, and Ventaleon GmbH, as Member-Supervisory Board.
Dr. Kaltofen-Ehmann received his graduate degree from Technische Universität München, undergraduate degree from the University of Koblenz, and Masters Business Admin degree from Kellogg School of Management.